Last updated on May 2019

Study of Safety and Efficacy of RVL-1201 in the Treatment of Blepharoptosis

Brief description of study

Phase 3 study to evaluate the safety and efficacy of treatment with RVL-1201 compared to placebo for treatment of blepharoptosis. Eligible subjects will be randomized to one of 2 treatment arms.

Clinical Study Identifier: NCT03565887

Recruitment Status: Closed

Brief Description Eligibility Contact Research Team

Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.